• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Which Recent FDA Webinars Are Most Useful for the LDT Rule?

Which Recent FDA Webinars Are Most Useful for the LDT Rule?

by Tara Cepull, MA | Jan 22, 2025 | Compliance Perspectives-lca, Essential, FDA-lca, Lab Industry Advisor

Regulatory expert Julie Ballard shares her thoughts on the most useful resources for labs as they get ready to comply with Stage 1

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Compliance Concerns: Laboratory Regulations in 2024 and Beyond

Compliance Concerns: Laboratory Regulations in 2024 and Beyond

by Michael Schubert, PhD | Jan 7, 2025 | CLIA-lca, CMS-lca, Compliance Perspectives-lca, Compliance-lca, Essential, Lab Industry Advisor, Legislation-lca

Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule

Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule

by Rachel Muenz | Nov 21, 2024 | Compliance Perspectives-lca, FDA-lca, Lab Industry Advisor, Premium

Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
What Labs Need to Know About Reporting Adverse Events to the FDA

What Labs Need to Know About Reporting Adverse Events to the FDA

by Tara Cepull, MA | Nov 1, 2024 | Compliance Perspectives-lca, Compliance-lca, Essential, FDA-lca, Lab Industry Advisor

Understanding the process and implementing proper procedures is the key to ensuring compliance when reporting such events

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Becoming Proficient in Proficiency Testing

Becoming Proficient in Proficiency Testing

by Michael Schubert, PhD | Jun 24, 2024 | CLIA-lca, Compliance-lca, Essential, Lab Industry Advisor

Quality expert Sten Westgard discusses the latest CLIA update: “It’s time to have performance goals built in this century”

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com